Pharmalys’ approach to corporate social responsibility reflects its long-standing commitment to advancing clinical research while contributing to sustainable and inclusive healthcare systems, particularly across the African continent.
Structured around three core pillars – Quality of Life, Equality and Fairness, and Standards of Work – these commitments guide the company’s actions across its operations and partnerships. They encompass support for improved access to healthcare, investment in professional development and training, the promotion of inclusive and equitable workplaces, and the continuous strengthening of clinical research standards.
Through its activities, Pharmalys contributes to several United Nations Sustainable Development Goals, including health and well-being, quality education, gender equality, and economic growth. This encompasses participation in vaccine development programmes, capacity-building initiatives for clinical research stakeholders, and targeted efforts to expand opportunities for early-career professionals.
These initiatives reflect a broader objective: to support the development of a robust, high-quality clinical research ecosystem capable of addressing global health challenges while ensuring that Africa is fully integrated into the future of clinical trials. #CountAfricaIn
Download the full Corporate Social Responsibility brochure here.
